肾下腹主动脉瘤腔内修复术后结局性别差异的系统评价与荟萃分析
女性30天死亡、院内死亡、肢体缺血、肾脏及心脏并发症和长期全因死亡风险显著增高,但内脏/肠系膜缺血、再干预及晚期内漏无显著性别差异。
要点
- 女性EVAR术后30天死亡风险显著高于男性(粗OR 1.67,95%CI 1.50-1.87)。
- 女性肢体缺血、肾脏及心脏并发症风险显著高于男性。
- 女性长期全因死亡风险显著增高(HR 1.23,95%CI 1.09-1.38)。
核心结论
- 女性肾下腹主动脉瘤EVAR术后30天死亡、院内死亡、肢体缺血、肾脏并发症、心脏并发症及长期全因死亡风险显著高于男性。
- 女性应接受严格且规律的EVAR术后长期监测。
研究设计与样本
- 二分类数据合并为比值比(OR),时间至事件数据合并为风险比(HR),采用随机效应模型。
主要发现
- 30天死亡率:粗OR 1.67(95%CI 1.50-1.87,P<.001),校正OR 1.73(95%CI 1.32-2.26,P<.001)。
- 院内死亡率OR 1.90(95%CI 1.43-2.53,P<.001),肢体缺血OR 2.44(95%CI 1.73-2.43,P<.001)。
- 肾脏并发症OR 1.73(95%CI 1.12-2.67,P=.028),心脏并发症OR 1.68(95%CI 1.01-2.80,P=.046)。
- 长期全因死亡率HR 1.23(95%CI 1.09-1.38,P=.001)。
- 内脏/肠系膜缺血、30天再干预、晚期内漏及晚期再干预无显著性别差异。
关键数值与推荐
- 完整AAA亚组中,女性内脏/肠系膜缺血风险显著增高(OR 1.85,95%CI 1.01-3.39,P=.046)。
- 完整AAA亚组中,女性心脏并发症风险与男性相当(OR 1.64,95%CI 0.85-3.17,P=.138)。
临床怎么用
- 女性EVAR术后应加强围手术期监护,重点关注肢体缺血、肾脏及心脏并发症。
- 女性EVAR术后应纳入严格且规律的长期随访监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Women face distinctive challenges when they receive endovascular aneurysm repair (EVAR) treatment, and according to the previous studies, sex differences in outcomes after EVAR for infrarenal abdominal aortic aneurysm (AAA) remains controversial. This study aimed to compare the short-term and long-term outcomes between women and men after EVAR for infrarenal AAA. METHODS: We conducted a comprehensive systematic review and meta-analysis of all available studies reporting sex differences after EVAR for infrarenal AAA, which were retrieved from the MEDICINE, Embase, and Cochrane Database. The pooled results were presented as odds ratios (ORs) for dichotomous data and hazard ratios for time-to-event data using a random effect model. RESULTS: Thirty-six cohorts were included in this meta-analysis. The pooled results showed that women were associated with a significantly increased risk of 30-day mortality (crude OR, 1.67; 95% confidence interval [CI], 1.50-1.87; P < .001; adjusted OR, 1.73; 95% CI, 1.32-2.26; P < .001), in-hospital mortality (OR, 1.90; 95% CI, 1.43-2.53; P < .001), limb ischemia (OR, 2.44; 95% CI, 1.73-2.43; P < .001), renal complications (OR, 1.73; 95% CI, 1.12-2.67; P = .028), cardiac complications (OR, 1.68; 95% CI, 1.01-2.80; P = .046), and long-term all-cause mortality (hazard ratio, 1.23; 95% CI, 1.09-1.38; P = .001) compared with men; however, no significant sex difference was observed for visceral/mesenteric ischemia (OR, 1.62; 95% CI, 0.91-2.88; P = .098), 30-day reinterventions (OR, 1.37; 95% CI, 0.95-1.98; P = .095), late endoleaks (OR, 1.18; 95% CI, 0.88-1.56; P = .264), and late reinterventions (OR, 1.05; 95% CI, 0.78-1.41; P = .741). In the intact AAA subgroup, women had a significantly increased risk of visceral/mesenteric ischemia (OR, 1.85; 95% CI, 1.01-3.39; P = .046) and an equivalent risk of cardiac complications (OR, 1.64; 95% CI, 0.85-3.17; P = .138) compared with men. CONCLUSIONS: Compared with male sex, female sex is associated with an increased risk of 30-day mortality, in-hospital mortality, limb ischemia, renal complications, cardiac complications, and long-term all-cause mortality after EVAR for infrarenal AAA. Women should be enrolled in a strict and regular long-term surveillance after EVAR.
引用
- Liu Y, Yang Y, Zhao J, et al. Systematic review and meta-analysis of sex differences in outcomes after endovascular aneurysm repair for infrarenal abdominal aortic aneurysm. J Vasc Surg. 2019. PMID: 31466739. doi:10.1016/j.jvs.2019.06.105
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。